Holen Sie sich die Stockscreener-App
10.21
4.49%
-0.48
Handel nachbörslich:
10.21
Schlusskurs vom Vortag:
$10.69
Offen:
$10.74
24-Stunden-Volumen:
171.95K
Relative Volume:
0.50
Marktkapitalisierung:
$94.47M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.42M
KGV:
-1.8228
EPS:
-5.6013
Netto-Cashflow:
$-7.45M
1W Leistung:
+9.55%
1M Leistung:
+9.43%
6M Leistung:
+381.60%
1J Leistung:
-39.73%
1-Tages-Spanne:
$9.61
$10.75
1-Wochen-Bereich:
$9.34
$10.89
52-Wochen-Spanne:
$1.80
$20.63
Cervomed Inc Stock (CRVO) Company Profile
Firmenname
Cervomed Inc
Sektor
Branche
Telefon
(617) 744-4400
Adresse
20 PARK PLAZA, BOSTON
Vergleichen Sie CRVO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
10.21 | 87.85M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-12-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-18 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-07-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Cervomed Inc Aktie (CRVO) Neueste Nachrichten
How high can CervoMed Inc. stock goWeekly Loss Report & Fast Exit and Entry Trade Guides - Newser
What’s the outlook for CervoMed Inc.’s sector2025 Sector Review & Breakout Confirmation Alerts - khodrobank.com
Can CervoMed Inc. lead its sector in growthMarket Activity Report & Verified Stock Trade Ideas - khodrobank.com
When is the best time to exit CervoMed Inc.2025 Risk Factors & Accurate Intraday Trade Tips - Newser
What to expect from CervoMed Inc. in the next 30 days2025 Key Highlights & Detailed Earnings Play Strategies - Newser
Will CervoMed Inc. rebound enough to break evenEntry Point & Safe Entry Momentum Tips - Newser
How institutional ownership impacts CervoMed Inc. stockM&A Rumor & Long-Term Safe Investment Ideas - Newser
What indicators show strength in CervoMed Inc.Trade Performance Summary & Weekly Watchlist of Top Performers - Newser
Risk adjusted return profile for CervoMed Inc. analyzed2025 Market WrapUp & Safe Entry Zone Tips - Newser
How does CervoMed Inc. compare to its peersWeekly Profit Summary & Free Community Consensus Stock Picks - khodrobank.com
Measuring CervoMed Inc.’s beta against major indices2025 Year in Review & Momentum Based Trading Ideas - Newser
Using economic indicators to assess CervoMed Inc. potentialJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
CervoMed Inc. to Present at Upcoming Investor Conferences in September 2025 - Quiver Quantitative
Is this a good reentry point in CervoMed Inc.Market Performance Report & Stock Portfolio Risk Control - Newser
CervoMed to Participate in Upcoming Investor Conferences - GlobeNewswire
Neurologic Drug Developer CervoMed Announces Dual Healthcare Conference Presentations in September 2025 - Stock Titan
Guidance Update: Can CervoMed Inc. navigate macro headwinds2025 Trading Volume Trends & Expert Approved Momentum Ideas - khodrobank.com
CervoMed Inc.’s volatility index tracking explainedPortfolio Gains Report & Daily Growth Stock Investment Tips - Newser
Why CervoMed Inc. is moving todayQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
CervoMed Inc. stock prediction for this weekWeekly Trend Summary & AI Forecasted Stock Moves - Newser
Is CervoMed Inc. stock a good pick for beginnersJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - khodrobank.com
Earnings visualization tools for CervoMed Inc.Market Trend Review & Advanced Swing Trade Entry Alerts - Newser
Is CervoMed Inc. showing signs of accumulationMarket Trend Review & Growth Focused Stock Reports - Newser
Chart based analysis of CervoMed Inc. trendsWeekly Loss Report & Low Drawdown Investment Ideas - Newser
Can CervoMed Inc. hit a new high this monthDollar Strength & Safe Investment Capital Preservation Plans - Newser
Regression analysis insights on CervoMed Inc. performanceEntry Point & Verified Short-Term Plans - Newser
EPS Watch: Will CervoMed Inc. benefit from government policyJuly 2025 Movers & Weekly Momentum Stock Picks - khodrobank.com
CervoMed's 15min chart shows KDJ Death Cross, bearish Marubozu formation detected. - AInvest
MACD Signals Flash Warning for CervoMed Inc. Stock getLinesFromResByArray error: size == 0 - thegnnews.com
Visualizing CervoMed Inc. stock with heatmaps2025 Sector Review & Fast Exit Strategy with Risk Control - Newser
How to track smart money flows in CervoMed Inc.July 2025 Chart Watch & AI Forecasted Entry and Exit Points - Newser
Smart tools for monitoring CervoMed Inc.’s price actionIndex Update & AI Driven Stock Reports - Newser
Volume spikes in CervoMed Inc. stock – what they meanMarket Trend Review & Daily Stock Momentum Reports - Newser
Exit strategy if you’re trapped in CervoMed Inc.Quarterly Portfolio Review & Fast Exit and Entry Trade Guides - Newser
CervoMed Inc. stock trend forecastInsider Selling & Consistent Profit Alerts - Newser
Finanzdaten der Cervomed Inc-Aktie (CRVO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):